Loading viewer...
investor_presentation
Format: PDF investor_presentation
uniQure presents corporate strategy and pipeline progress in gene therapy, focusing on AMT-130 development for Huntington's disease treatment. The presentation outlines clinical trial data, biomarker utility for target engagement, and regulatory pathway advancement in the U.S. and Europe.
investor_presentation
42 Pages
Sapiens
Vinhomes Corporate Presentation May 2023
investor_presentationinvestor_presentation
17 Pages
Vinhomes Joint Stock Company